Resultados de la búsqueda 91-100 of 10589 for breast implants

  1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer.

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    ... breast cancer and age-matched healthy controls. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    ... breast cancer and age-matched healthy controls. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Many breast cancer survivors report cancer-related cognitive impairment, which this has recently become a priority in clinical research due to its dramatic ...

  9. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...